. Chemical structures of the unnatural amino acid Nε-Boc-L-lysine (BocK) and the clickable fluorescent azide 5-carboxytetramethylrhodamine-PEG3-azide (TAMRA-N3) used in this study. Figure S2 . Electrophoretic mobility shift assay (EMSA) with IRP1(R780Q) and the FTH-IRE RNA probe; native PAGE, radioautography. Figure S3 . A time-course analysis of the crosslinking between the DiAzKs mutants of IRP1 and the FTH-IRE RNA upon irradiation with the 1 kW mercury/xenon lamp (wavelength >345 nm); see Table  S2 for the description of the light source.
A B Figure S4 . (A) The crosslinking between IRP1(A687DiAzKs) and the wild-type FTH-IRE RNA upon irradiation with either the 1 kW mercury/xenon lamp (λ > 345 nm) or with the Spectrolinker XL-1500 UV crosslinker (λ = 365 nm); see Table S2 for descriptions of the light sources. (B) A plot of conversion vs crosslinking time and data fitting as a first order chemical reaction. Table S1 . RNA probes used in this study Probe Sequence (5' to 3') wt-IRE UUUUUGUUUCCUGCUUCAACAGUGCUUGGACGGAAC IRE-ΔC UUUUUGUUUCCUGCUUCAA-AGUGCUUGGACGGAAC 
Materials and methods
General chemicals. Reagents for gel electrophoresis were purchased from BioRad or Invitrogen. The fluorescent dye and the reagents for Cu-catalyzed azide-alkyne cycloaddition were from Sigma Aldrich. Unnatural amino acids. Nε-Boc-L-lysine (BocK) was purchased from Sigma-Aldrich. The diazirinebased unnatural amino acids DiAzKs and PrDiAzK were synthesized as described earlier [S1, S2] . For bacterial expression, 80 mM stock solutions of the unnatural amino acids in 0.1 M NaOH were prepared, aliquoted, flash-frozen in liquid nitrogen and stored at -20 °C. Oligonucleotides, plasmids and cloning. DNA primers for cloning and IRE RNA probes for the binding and crosslinking experiments were purchased from Sigma Aldrich. RNA oligonucleotides were dissolved in nuclease-free water (Ambion), aliquoted and stored at -80 °C. The 5'-end labeling of the RNA probes was performed using T4 polynucleotide kinase (New England Biolabs) and [γ-32 P]-ATP (Hartmann Analytic GmbH); the end-labeled RNA probes were purified using Sephadex G-25 desalting spin columns (GE Healthcare) according to manufacturer's procedure and stored as 3 μM stocks in nuclease-free water at -80 °C. Plasmid pBAD-FLAG-EGFP(Y39TAG)-His6 encoding the green fluorescent protein with the amber stop codon at the amino acid position 39, flanked by Nterminal FLAG-tag and C-terminal polyhistidine affinity tag was described previously [S3] . The bacterial amber suppression plasmid pEvol-MmPylRS(Y306A/Y384F)-PylTCUA harboring the double AF-mutant of Methanosarcina mazei pyrrolysyl aminoacyl-tRNA synthetase and the suppressor pyrrolysyl tRNACUA was described previously [S3] . Plasmid pT7-7-His6-IRP1(wt) encoding the human iron-regulating protein 1 (UniProt P21399) with N-terminal polyhistidine affinity tag described previously [S4] was subjected to oligonucleotide-directed mutagenesis. First, the amber stop codon (TAG) terminating the IRP1 open reading frame in the original plasmid was mutated into ochre stop codon (TAA). This plasmid was used for the expression and purification of the recombinant wild-type IRP1. The same plasmid was also used for the generation of the IRP1(R780Q) mutant by mutating codon 780 (CGA) into CAG giving the plasmid pT7-7-His6-IRP1(R780Q), and for the generation of the amber mutants of IRP1 by mutating codons 536 (AGG) and 687 (GCA) into TAG, giving plasmids pT7-7-His6-IRP1(R536TAG) and pT7-7-His6-IRP1(A687TAG), respectively. The sequence of the obtained mutants of IRP1 was confirmed by Sanger sequencing (GATC Biotech/Eurofins Genomics). Three overlapping sequencing reactions were used to cover the 2.7 kb open reading frame of the IRP1. Bacterial strain E.coli XL1-Blue was used for cloning and plasmid amplification. Plasmid isolations were performed using QIAgen kits. Plasmid concentration was measured on a Nanodrop (Thermo Fisher Scientific).
Protein expression, purification and labeling
Expression, affinity purification and click labeling of the uAA mutants of GFP. Electrocompetent E.coli BL21-AI were co-transformed with the plasmids pBAD-FLAG-EGFP(Y39TAG)-His6 and pEvol-MmPylRS(Y306A/Y384F)-PylTCUA using the Gene Pulser Xcell Electroporation Systems (BioRad). The bacteria were resuspended in SOC medium, incubated for 1h at 37 °C to recover, plated on LB-agar plates with ampicillin (100 μg/mL) and chloramphenicol (33 μg/mL) and the plate was incubated at 37 °C for 18-22 hours. A single colony was used to inoculate 5 mL of LB medium supplemented with ampicillin (100 μg/mL) and chloramphenicol (25 μg/mL), and then the preculture was incubated on a thermostated rotor at 37 °C for 12-14 hours. The preculture (200 μL) was used to inoculate 15 mL of pre-warmed Terrific Broth (TB) medium supplemented with ampicillin (100 μg/mL) and chloramphenicol (25 μg/mL). The cultures were incubated in Erlenmeyer flasks on a thermostated orbital shaker (37 °C, 180 rpm) until OD600 reached ~ 0.1 -0.2; at this point, 190 μL of the 80 mM stock solution of corresponding unnatural amino acid in 0.1 M NaOH was added dropwise to give a final concentration of 1 mM (190 μL of 0.1 M NaOH were used for the negative control). The cultures were allowed to grow until OD600 reached ~ 0.3 -0.4 at which point protein expression was induced by adding 15 μL of 20% w/v L-arabinose solution. The culture was incubated on the shaker (37 °C, 180 rpm) overnight. The cells were harvested by centrifugation (2500 rcf, 20 min, 4 °C) and the pellets were stored at -20 °C. For protein isolation, the pellets were resuspended in icecold phosphate-buffered saline (PBS) supplemented with 5 mM imidazole and cOmplete EDTA-free protease inhibitor cocktail (Roche). The cells were lysed by sonication at 4°C (Branson Sonifier 250, output control 1, duty cycle 50%, 60 -70 sec). The lysate was cleared by centrifugation (18000 rcf, 15 min, 4°C), the supernatant was mixed with 100 μL of Ni-NTA agarose beads (Qiagen) preequilibrated against the PBS with 5 mM imidazol. The suspension was kept on a tube rotator for 1-2 h (4°C, 10 rpm). The beads were collected and transferred into a gravity-flow Mobicol column (Mobitec) and washed with PBS supplemented with 10 mM imidazol (10 mL) and then with PBS supplemented with 20 mM imidazol (2 mL). The protein was eluted using PBS supplemented with 250 mM imidazol (3 × 100 µL), and then the combined protein elution was concentrated in neat PBS using Amicon Ultra centrifugal filters (10 kDa cutoff). The concentration was determined by measuring absorbance at 494 nm on a Nanodrop. For gel electrophoresis analysis, 2 µL of the concentrated protein sample was mixed with 19 µL of PBS and 7 µL of 4x NuPAGE LDS sample buffer supplemented with 1 mM DTT. The samples were denatured by heating (97 °C, 15 min), cooled down to room temperature and 15 µL of each sample were analyzed by SDS-PAGE (precast NuPAGE 4-12% Bis-Tris protein gels, MOPS SDS running buffer, 150V, 1 hour). After the electrophoresis, the gel was rinsed with water (3 × 10 min on a shaker) and then stained with InstantBlue Coomassie protein stain (Expedeon). For protein labeling with Cu-catalyzed azide-alkyne cycloaddition (CuAAC), the following stock solutions were prepared and stored at -20 °C: 25 mM sodium L-ascorbate in H2O, 2.5 mM tris(benzyltriazolylmethyl)amine (TBTA) in DMSO, 25 mM CuSO4 in H2O; 2 mM Azide-fluor 545 (TAMRA-PEG3-azide, SigmaAldrich) in DMSO. The click master mix was freshly prepared by mixing equal volumes of PBS and the stock solutions of TBTA, CuSO4, ascorbic acid and Azidefluor 545. For negative controls, a mock master mix lacking CuSO4 was prepared. The CuAAC reaction was initiated by mixing 10 µL of 1.2 μM GFP solution in PBS and 2.5 µL of the click (or mock) master mix and the resulting solution was incubated for 1 hour at 23 °C. After that time, the volume of samples was adjusted to 25 μL with PBS, 9 µL of 4x NuPAGE LDS sample buffer supplemented with 1 mM DTT was added and the samples were denatured by heating (97 °C, 15 min). Portions of 9 µL of each sample were analyzed by SDS-PAGE (precast NuPAGE 4-12% Bis-Tris protein gels, MOPS SDS running buffer, 150 V, 1 hour). After running, the gel was rinsed with water (3 × 10 min on a shaker) and then the gel was soaked in H2O/MeOH/CH3COOH mixture (5/4/1, v/v; 4 °C, overnight) to remove the excess of the TAMRA-PEG-azide from the gel. Next day the gel was again rinsed with water at room temperature (3 × 15 min on a shaker) and then the in-gel fluorescence was recorded using a Typhoon FLA 9500 imager with the following settings: λex = 532 nm, LPG emission filter (575 nm cut-off). The same gel was stained using the InstantBlue Coomassie protein staining reagent. IRP1 and IRP1(R780Q) . Competent E. coli NiCo21 (DE3) cells (New England Biolabs) were transformed with the plasmid pT7-7-His6-IRP1(wt) or with the plasmid pT7-7-His6-IRP1(R780Q) according to the manufacturer's instruction. The recovered cells were plated on LB-agar plates with ampicillin (100 μg/mL) and the plates were incubated at 37 °C for 18-22 hours. Individual colonies were used to inoculate precultures (5 mL of LB medium with 100 μg/mL of ampicillin). The precultures were kept on a rotor at 37 °C for 12-14 hours and then 200 μL of the precultures were used to inoculate expression medium (50 mL of pre-warmed TB supplemented with 100 μg/mL of ampicillin). The cultures were incubated in Erlenmeyer flasks on a thermostated orbital shaker (25 °C, 180 rpm) for 32 hours without adding any small-molecule inducer. The cells were harvested by centrifugation (2500 rcf, 30 min, 4 °C), the pellets were resuspended in 2 mL of lysis buffer (50 mM Tris pH 8.0, 250 mM NaCl, 10 mM imidazol, 0.5% NP-40) and the suspension were stored at -20 °C. For protein isolation, the frozen suspension was thawed and cOmplete EDTA-free protease inhibitor cocktail (Roche) was added. The cells were lysed by sonication at 4°C (Branson Sonifier 250, output control 1, duty cycle 50%, 70 -80 sec). The lysate was cleared by centrifugation (18000 rcf, 15 min, 4°C), the supernatant was transferred into a clean tube and the centrifugation was repeated (18000 rcf, 10 min, 4°C). The cleared lysate was mixed with 200 μL of Ni-NTA agarose beads pre-equilibrated against the lysis buffer. The suspension was kept on a tube rotator for 1-1.5 hours (4 °C, 10 rpm). After that, the supernatant was aspirated and the beads were washed in the same tube by adding and aspirating (3 × 3 mL) ice-cold buffer (50 mM Tris pH 8.0, 250 mM NaCl, 15 mM imidazol, 0.5% NP-40). Then the beads were transferred into 2.5 mL gravity flow columns with 90 µm filter pore size (Mobitec) where they were sequentially washed with 50 mM Tris pH 8.0, 250 mM NaCl buffer supplemented with 10 mM imidazole (25 mL) and then with the same buffer supplemented with 20 mM imidazole (10 mL). The protein was eluted from the beads using 50 mM Tris pH 8.0, 250 mM NaCl, 250 mM imidazole, 0.5% NP-40 buffer (5 × 150 µL) and the pooled elution fractions were combined with 600 µL of chitin beads (New England Biolabs) pre-equilibrated against the lysis buffer. The suspension was incubated on the tube rotator for 30-40 min (4 °C, 10 rpm). The supernatant containing the purified target protein was separated from the beads by filtration and then concentrated in the storage buffer (20 mM Tris pH 7.4, 100 mM NaCl, 0.1 mM EDTA, 5 mM DTT, 10% glycerol) [S5] using Amicon Ultra centrifugal filters (50 kDa cutoff). The purified protein was stored at -80 °C. Quantification was performed by comparison with BSA standards (ThermoFisher) on Coomassie-stained SDS/polyacrylamide gel.
Expression and affinity purification of the human wild-type

Expression and affinity purification of the unnatural amino acids of IRP1
Competent E. coli NiCo21(DE3) cells were co-transformed with two plasmids (pEvol- MmPylRS(Y306A/Y384F)-PylTCUA and pT7-7-His6-IRP1(xxxTAG) ) according to the manufacturer's instruction, and the recovered cells were plated on LB-agar plates with ampicillin (100 μg/mL) and chloramphenicol (33 μg/mL). The plates were incubated at 37 °C for 18-20 hours. Individual colonies were used to inoculate precultures (5 mL of LB medium with 100 μg/mL ampicillin and 25 μg/mL chloramphenicol). The precultures were kept on a rotor at 37 °C for 12-14 hours. The precultures (200 µL) were used to inoculate 50 mL of pre-warmed TB medium supplemented with ampicillin (100 μg/mL), chloramphenicol (25 μg/mL) and corresponding unnatural amino acid (1 mM final concentration). The cultures were incubated in Erlenmeyer flasks on thermostated orbital shaker (25 °C, 180 rpm) until OD600 reached ~ 0.1 -0.2; at this point 50 μL L-arabinose in water (20% w/v) was added. The cultures were kept on the orbital shaker (25 °C, 180 rpm) until 32 -35 hours post-inoculation. The isolation of the uAA-labeled IRP1 mutans was performed according to the procedure described above for the wild-type protein.
Electrophoretic mobility shift assay for Kd and binding specificity measurements
Binding mixtures (30 μL each) for electrophoretic mobility shift assay (EMSA) were prepared as follows. First, 0.6 µL of corresponding 3 µM [ 32 P]-end-labeled RNA probe and 6 µL of 5x EMSA buffer (50 mM Hepes pH 7.6, 15 mM MgCl2, 200 mM KCl, 25% glycerol, was added to 20.9 µL of nuclease-free water (Ambion) and the solution was mixed by vortexing. The solution was heated for 3 min at 70 °C and then cooled down to 21 °C during 6 min to refold the RNA probe. Then, 2.5 μL of the protein storage buffer (20 mM Tris pH 7.4, 100 mM NaCl, 0.1 mM EDTA, 5 mM DTT, 10% glycerol) containing variable amounts of corresponding recombinant IRP1 was added and the solutions were mixed by pipeting. For Kd measurements, the final protein concentration in the binding solution was in a range of 0 -165 nM for IRP1(wt) and the unnatural amino acid mutants, and in a range of 0 -502 nM for IRP1(R780Q). For binding specificity measurements, the final protein concentration was 50 nM for IRP1(wt) and the unnatural amino acid mutants. The binding mixtures were incubated for 30 min at room temperature (21-23 °C). Then, 3 μL of 80% glycerol was added, the samples were mixed by pipeting and analyzed by 5% native polyacrylamide gel electrophoresis (16 cm gel, 0.5x TBE buffer, 90 V, 25 -30 min run). The gel was dried in vacuo (50 °C, 1 hour) and then visualized by phosphorimaging using Storage Phosphor Screens (GE Healthcare) and Typhoon FLA 9500 imager. The images were quantified using the gel analysis feature of the Fiji software [S6] to measure Frb ("RNA fraction bound") values. For Kd calculations, Frb was plotted as a function of protein concentration and fitted in GraphPad Prism v4.0 using the "One site / Specific binding" model. The binding specificity was measured as (1 -Frb (ΔC-IRE))/(1 -Frb (wt-IRE)).
In vitro crosslinking
Binding mixtures (30 μL) were prepared as described above with the final protein concentration of 100 nM. After the incubation for 30 min at room temperature, the samples were placed on ice. Next, 15 μL of each sample were pipetted into separate tubes and kept in darkness on ice, whereas the remaining 15 μL were irradiated with UV light using one of the crosslinking setups described above (Table S2 ). Then, 15 μL of 2x RNA loading dye (ThermoFisher; 95% formamide 0.025% SDS 0.025% bromophenol blue 0.025% xylene cyanol FF 0.025% ethidium bromide 0.5 mM EDTA) was added to each sample. They were denatured by heating (60 °C, 3 min) and analyzed by SDS-PAGE (precast NuPAGE 4-12% Bis-Tris protein gels, MOPS SDS running buffer, 150V, 1 hour). The gel was dried in vacuo (50 °C, 1 hour) and then visualized by phosphorimaging using Storage Phosphor Screens (GE Healthcare) and Typhoon FLA 9500 imager.
Informatics and statistical analysis
Visualization of the IRP1-IRE complex and the selection of proximal amino acid positions for the incorporation of the photocrosslinker was performed using the UCSF Chimera [S7] . The gels were quantified using Fiji software [S6] . The bar graphs in Figures 3-5 represent mean ± SEM for three replicates done with at least two independently expressed and purified protein batches. Student's t test was used, and p-values are indicated in the figure legends; p < 0.05 was considered statistically significant.
